Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy

Willemse, Peter-Paul M.Davis, Niall F.Grivas, NikolaosZattoni, FabioLardas, MichaelBriers, ErikCumberbatch, Marcus G.De Santis, MariaDell'Oglio, PaoloDonaldson, James F.Fossati, NicolaGandaglia, GiorgioGillessen, SilkeGrummet, Jeremy P.Henry, Ann M.Liew, MatthewMacLennan, StevenMason, Malcolm D.Moris, LisaPlass, KarinO'Hanlon, ShaneOmar, Muhammad ImranOprea-Lager, Daniela E.Pang, Karl H.Paterson, CatherinePloussard, GuillaumeRouvière, OlivierSchoots, Ivo G.Tilki, Deryavan den Bergh, Roderick C.N.van den Broeck, Thomasvan der Kwast, Theodorus H.van der Poel, Henk G.Wiegel, ThomasYuan, Cathy YuhongCornford, PhilipMottet, NicolasLam, Thomas B.L.2022-12-022022-12-022022-04-01Willemse, P-P M, Davis, N F, Grivas, N, Zattoni, F, Lardas, M, Briers, E, Cumberbatch, M G, De Santis, M, Dell'Oglio, P, Donaldson, J F, Fossati, N, Gandaglia, G, Gillessen, S, Grummet, J P, Henry, A M, Liew, M, MacLennan, S, Mason, M D, Moris, L, Plass, K, O'Hanlon, S, Omar, M I, Oprea-Lager, D E, Pang, K H, Paterson, C, Ploussard, G, Rouvière, O, Schoots, I G, Tilki, D, van den Bergh, R C N, van den Broeck, T, van der Kwast, T H, van der Poel, H G, Wiegel, T, Yuan, C Y, Cornford, P, Mottet, N & Lam, T B L 2022, 'Systematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategy', European Urology, vol. 81, no. 4, pp. 337-346. https://doi.org/10.1016/j.eururo.2021.12.0070302-2838ORCID: /0000-0002-2691-8421/work/110638014ORCID: /0000-0002-1597-3126/work/110638144https://hdl.handle.net/2164/1966610401298engSDG 3 - Good Health and Well-beingSystematic reviewactive surveillancelocalized prostate cancerconsensus statementscriteria for inclusion and eligibilitymonitoring and reclassificationpositive corescore involvementper-protocol or untriggered repeat biopsiesclinical practice guidelines and recommendationsR MedicineSupplementary DataRSystematic review of active surveillance for clinically localized prostate cancer to develop recommendations regarding inclusion of intermediate-risk disease, biopsy characteristics at inclusion and monitoring, and surveillance repeat biopsy strategyJournal article10.1016/j.eururo.2021.12.007814